[{"id":"89c725c9-e95c-4a50-a2e0-56a79f7ec50f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05372692","created_at":"2022-05-13T12:54:25.449Z","updated_at":"2024-07-02T16:35:42.810Z","phase":"","brief_title":"Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer","source_id_and_acronym":"NCT05372692","lead_sponsor":"Weijia Fang, MD","biomarkers":" MSLN","pipe":"","alterations":" ","tags":["MSLN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LD013"],"overall_status":"Completed","enrollment":" Enrollment 3","initiation":"Initiation: 04/12/2022","start_date":" 04/12/2022","primary_txt":" Primary completion: 02/01/2023","primary_completion_date":" 02/01/2023","study_txt":" Completion: 02/01/2023","study_completion_date":" 02/01/2023","last_update_posted":"2023-07-17"}]